These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 3311572

  • 21. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR.
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [Abstract] [Full Text] [Related]

  • 22. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ.
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [Abstract] [Full Text] [Related]

  • 23. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL, Figueroa-Damián R, Rosas A, Jáuregui A, Corral M, Costa A, Merlos RM, Ríos-Fabra A, Amábile-Cuevas CF, Hernández-Oliva GM, Olguín J, Cardeñosa-Guerra O, uUTI Latin American Study Group.
    J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA, Jones RN, Leeds JA, Denys G, Sader HS, Fritsche TR.
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.
    Vila J, Sánchez-Céspedes J, Sierra JM, Piqueras M, Nicolás E, Freixas J, Giralt E.
    Int J Antimicrob Agents; 2006 Jul; 28(1):19-24. PubMed ID: 16781123
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Norfloxacin in the therapy of gonococcal infections.
    Romanowski B.
    Scand J Infect Dis Suppl; 1986 Jul; 48():40-5. PubMed ID: 3095917
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
    Parras F, Torroba L, Buzón L, Martínez-Beltrán J, Loza E, Baquero F.
    Enferm Infecc Microbiol Clin; 1989 May; 7(5):261-5. PubMed ID: 2490722
    [Abstract] [Full Text] [Related]

  • 39. Symposium on antimicrobial agents. The quinolones.
    Walker RC, Wright AJ.
    Mayo Clin Proc; 1987 Nov; 62(11):1007-12. PubMed ID: 3312850
    [Abstract] [Full Text] [Related]

  • 40. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M, Naber KG, Kinzig-Schippers M, Sörgel F.
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.